Cerus Corporation
NASDAQ:CERSMedical - Devices
+$0.08 today
- Market cap
- $391.79M
- Beta
- 1.77
- P/E (TTM)
- -53.8
- EPS (TTM)
- -$0.05
Volume 6.09M
Average 2.33M
CERS Other Non-current Assets
Long-term assets not reported separately.
Cerus CorporationNASDAQ: CERS
Other Non-current Assets · Q1 FY2026 · quarter ended Mar 2026
Other non-current assets broadly unchanged from a year ago
Other non-current assets stood at $27.55M at the end of Q1 FY2026, down 0.9% from a year earlier and up 2.7% from the prior quarter. Over 3 fiscal years it compounded at +5.0% a year.
Context
- Other non-current assets amounted to 12.4% of total assets at the end of Q1 FY2026, down 1.1 pp from a year earlier.
- Other non-current assets increased in 1 of the last 3 fiscal years.
What to watch
Whether other non-current assets keeps falling in the next quarterly balance sheet after a -0.9% change from a year earlier.
Sources:Balance SheetText generated from reported figures; not investment advice.
Other Non-current Assets history
USD · from the balance sheet
- Latest · FY2025
- 26.83M USD
- Year-over-year change
- -16.3%
- 4-year CAGR
- +2.9%
| Period | Period end | Other Non-current Assets | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 26.83M | -16.3% |
| FY2024 | 2024-12-31 | 32.04M | -1.8% |
| FY2023 | 2023-12-31 | 32.64M | +41.0% |
| FY2022 | 2022-12-31 | 23.15M | -3.1% |
| FY2021 | 2021-12-31 | 23.9M | — |
Other Non-current Assets vs competitors
How CERS compares with its peers on the latest reported figures
- Peers report in different currencies, so other non-current assets is compared through growth and share of total assets rather than absolute size.
- Its year-over-year change of -0.9% is the 2nd highest of 4, against a peer median of -5.8%.
- Other non-current assets amounts to 12.4% of total assets for CERS, versus a peer median of 1.3%.
| Company | Period | Latest balance | YoY | 3-year CAGR | % of assets |
|---|---|---|---|---|---|
| Jun 2026 | $149.96M USD | -18.2% | +9.8% | 6.3% | |
| Jun 2026 | €30M EUR | -5.8% | -49.5% | 0.1% | |
| Mar 2026 | $27.55M USD | -0.9% | +5.0% | 12.4% | |
| Jun 2026 | $9.13M USD | +0.7% | +21.7% | 1.3% | |
| Peer median (excluding CERS) | — | -5.8% | +9.8% | 1.3% | |
Competitors are the stored peer set for CERS. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Balance Sheet
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Cash & Equivalents | 48.76M | 35.59M | 11.65M | 20.27M | 19.96M |
| Short-term Investments | 80.6M | 66.57M | 54.21M | 60.19M | 62.92M |
| Net Receivables | 25.13M | 34.43M | 35.5M | 29.78M | 30.37M |
| Inventory | 26.79M | 29M | 39.87M | 38.15M | 56.1M |
| Other Current Assets | 0 | 4.56M | 3.22M | 3.64M | 5.03M |
| Total Current Assets | 187.1M | 170.14M | 144.44M | 152.02M | 174.38M |
| Property, Plant & Equipment (Net) | 25.18M | 23.48M | 19.35M | 15.54M | 19.33M |
| Goodwill | 1.32M | 1.32M | 1.32M | 1.32M | 1.32M |
| Intangible Assets | 0 | 0 | 0 | 0 | 0 |
| Long-term Investments | 0 | 0 | 0 | 0 | 0 |
| Tax Assets | 0 | 0 | 0 | 0 | 0 |
| Other Non-current Assets | 23.9M | 23.15M | 32.64M | 32.04M | 26.83M |
| Total Non-current Assets | 50.4M | 47.95M | 53.31M | 48.9M | 47.48M |
| Total Assets | 237.5M | 218.09M | 197.75M | 200.92M | 221.86M |
| Account Payables | 35.61M | 33M | 23.84M | 21.7M | 28.01M |
| Short-term Debt | 14.7M | 56.16M | 20M | 19.3M | 43.34M |
| Tax Payables | 0 | 0 | 0 | 0 | 0 |
| Deferred Revenue | 673K | 589K | 2M | 1.4M | 1.27M |
| Other Current Liabilities | 18.51M | 17.58M | 11.82M | 11.94M | 18.26M |
| Total Current Liabilities | 78.56M | 117.06M | 67.52M | 63.61M | 100.8M |
| Long-term Debt | 54.72M | 13.64M | 59.8M | 64.86M | 40.55M |
| Deferred Tax Liabilities | 0 | 0 | 0 | 0 | 0 |
| Deferred Revenue (Non-current) | 0 | 0 | 0 | 0 | 0 |
| Other Non-current Liabilities | 2.34M | 3.5M | 3.24M | 3.89M | 5.4M |
| Total Non-current Liabilities | 73.33M | 32.47M | 76.78M | 80.41M | 56.09M |
| Total Liabilities | 151.88M | 149.53M | 144.3M | 144.02M | 156.89M |
| Common Stock | 174K | 177K | 181K | 186K | 192K |
| Retained Earnings | (964.34M) | (1.01B) | (1.04B) | (1.07B) | (1.08B) |
| Accumulated OCI | (149K) | (2.79M) | (1.27M) | (400K) | (156K) |
| Other Stockholders Equity | 0 | 0 | 0 | 0 | 0 |
| Minority Interest | 998K | 952K | 794K | 751K | 741K |
| Total Equity | 85.62M | 68.56M | 53.44M | 56.9M | 64.97M |
| Total Debt | 87.59M | 87.24M | 96M | 98.1M | 96.95M |
| Net Debt | 38.83M | 51.65M | 84.35M | 77.83M | 76.99M |
Cerus Corporation
NASDAQ:CERS
Intrinsic Alpha fair value
Locked
Current Price
$1.94
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.